Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening
Medicinal Chemistry Research · 2024-08 · 33 (8) · 1450-1463
DOI: 10.1007/s00044-024-03290-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinal Chemistry Research, online erschienen am 28.07.2024. Verfasst von Kelsey E. Lubin und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Many potential neurotherapeutic agents fail in the later stages during development due to insufficient blood-brain barrier (BBB) permeability or neurotoxic effects. To address this, we developed an in vitro model incorporating the neurovascular unit (NVU) — astrocytes, pericytes, neurons, and brain microvessel endothelial cells — designed to simulate the in vivo BBB and improve early drug screening. This model uses a direct contact triculture system enhanced by integrating SH-SY5Y neuron-like cells, enabling the study of permeability-linked neuronal responses. Our results show that this expanded NVU model, employing a Transwell® system, enhances the BBB’s restrictive properties and neuronal viability, potentially due to improved cell-cell signaling. Additionally, the model demonstrated increased efflux transporter expression, providing a more physiologically relevant assessment of neuroactivity in relation to BBB permeability. This innovative NVU model offers a predictive and robust tool for evaluating neurotherapeutic agents, facilitating the prioritization of candidates in large compound libraries and potentially reducing attrition rates in drug development. It represents a significant advancement in the methodology for early-stage neurotherapeutic screening, aligning in vitro findings more closely with in vivo responses.
Zitieren
APA
Lubin, K. E., Xu, Z., Sluka, J. P., & Knipp, G. T. (2024). Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening. Medicinal Chemistry Research, 33(8), 1450-1463. https://doi.org/10.1007/s00044-024-03290-4
Vancouver
Lubin KE, Xu Z, Sluka JP, Knipp GT. Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening. Medicinal Chemistry Research. 2024;33(8):1450-1463. doi:10.1007/s00044-024-03290-4
BibTeX
@article{Lubin2024,
author = {Lubin, Kelsey E. and Xu, Zhuangyan and Sluka, James P. and Knipp, Gregory T.},
title = {Development of an in vitro model of the neurovascular unit for BBB permeability-linked neuroactivity screening},
journal = {Medicinal Chemistry Research},
year = {2024},
volume = {33},
number = {8},
pages = {1450--1463},
doi = {10.1007/s00044-024-03290-4}
}
EUVIMED